Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02714140 · ClinicalTrials.gov registry record · NA

Does Preference-based HIV Testing Increase Uptake in High Risk Populations?

A NA study, sponsored by University of South Carolina.

Completed
Registry status
NA
Development phase
1,194
Enrollment target

NCT02714140 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 1,194 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02714140, a NA study, has completed, sponsored by University of South Carolina.

COMPLETED
Registry status
NA
Development phase
1,194 participants
Enrollment target

Study Summary

Despite worldwide efforts to promote HIV Counseling and Testing (HCT), rates of testing remain low. Understanding how high risk groups decide to test and adapting available testing options to their preferences has the potential to broadly improve HCT uptake and cost-effectiveness. This study proposes to use a Discrete Choice Experiment, a survey method increasingly used by health economists for the design of patient-centered health care options, to rigorously quantify HIV testing preferences among two high-risk populations, identify their preferred testing options, and evaluate, in a pragmatic randomized controlled trial (RCT), the effect of a preference-based HIV counseling and testing (PB-HCT) intervention on testing uptake. At a time of heightened focus on health preferences research and patient-centered care, this study evaluates the critical link between preference-based intervention design and efficacy. If the RCT indicates that PB-HCT increases testing rates, the testing options evaluated in this R01 can be offered to high-risk populations in the study area, and the preference elicitation method and tools can be used to inform the design of testing options that better match the preferences of other high-risk populations and in other settings.

Interventions

  • BEHAVIORAL PB-HCT +
  • BEHAVIORAL PB-HCT -
  • BEHAVIORAL Economic incentive
  • BEHAVIORAL PB-HCT ++
  • BEHAVIORAL SMS Reminder

Trial Details

FieldValue
Enrollment Target 1,194 participants
Start Date 2018-01-03
Est. Completion 2020-10-31
Phase NA

Sponsor

University of South Carolina

157 total trials

What the Registry Record Tells You About NCT02714140

The ClinicalTrials.gov registry entry for NCT02714140 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which PB-HCT + is the first listed.

NCT02714140 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02714140 about?

NCT02714140 is a clinical study titled "Does Preference-based HIV Testing Increase Uptake in High Risk Populations?". Despite worldwide efforts to promote HIV Counseling and Testing (HCT), rates of testing remain low. Understanding how high risk groups decide to test and adapting available testing options to their preferences has the potential to broadly improve HCT uptake and cost-effectiveness. This study propose...

What is the current status of trial NCT02714140?

This trial is currently completed. It is a NA study. The enrollment target is 1,194 participants. The study started on 2018-01-03. Estimated completion is 2020-10-31.

What interventions are being tested in trial NCT02714140?

The interventions under investigation include: PB-HCT + (BEHAVIORAL), PB-HCT - (BEHAVIORAL), Economic incentive (BEHAVIORAL), PB-HCT ++ (BEHAVIORAL), SMS Reminder (BEHAVIORAL).

Who is sponsoring clinical trial NCT02714140?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.